324 related articles for article (PubMed ID: 15720613)
1. An international collaborative study to replace the 1st international standard for prekallikrein activator.
Longstaff C; Behr-Gross ME; Daas A; Lackner F
Vox Sang; 2005 Feb; 88(2):143-51. PubMed ID: 15720613
[TBL] [Abstract][Full Text] [Related]
2. Collaborative study to establish a new biological reference preparation for prekallikrein activator.
Longstaff C; Behr-Gross ME; Daas A; Lackner F
Pharmeuropa Bio; 2005 Sep; 2005(1):1-12. PubMed ID: 16336933
[TBL] [Abstract][Full Text] [Related]
3. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
[TBL] [Abstract][Full Text] [Related]
4. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
Stickings P; Rigsby P; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
[TBL] [Abstract][Full Text] [Related]
5. Calibration of human coagulation factor VIII concentrate Ph. Eur. BRP Batch 4 for use in potency assays.
Raut S; Costanzo A; Daniels S; Heath A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):1-29. PubMed ID: 21144486
[TBL] [Abstract][Full Text] [Related]
6. A collaborative study to establish the 1st national standard of prekallikrein activator in Korea.
Shin IS; Hong CM; Ban SJ; Hong SH
Biologicals; 2012 Jan; 40(1):79-83. PubMed ID: 22122985
[TBL] [Abstract][Full Text] [Related]
7. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
[TBL] [Abstract][Full Text] [Related]
8. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
Buchheit KH; Daas A; Stalder J
Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
[TBL] [Abstract][Full Text] [Related]
9. Establishment of replacement batches for prekallikrein activator in albumin biological reference preparation.
Lackner F; Daas A; Terao E; Behr-Gross ME
Pharmeuropa Bio; 2008 Dec; 2008(1):1-6. PubMed ID: 19220976
[TBL] [Abstract][Full Text] [Related]
10. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
Meager A; Das RG
J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
[TBL] [Abstract][Full Text] [Related]
11. Establishment of the European Pharmacopoeia Biological Reference Preparation (Ph. Eur. BRP) for hepatitis A vaccine type B (Aventis Pasteur) batch 2.
Buchheit KH; Daas A
Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):95-108. PubMed ID: 12448033
[TBL] [Abstract][Full Text] [Related]
12. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2.
Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a biological reference preparation for hepatitis A vaccine (inactivated, non-adsorbed).
Stalder J; Costanzo A; Daas A; Rautmann G; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):15-29. PubMed ID: 20223187
[TBL] [Abstract][Full Text] [Related]
14. Collaborative study for the calibration of the Ph. Eur. prekallikrein activator in albumin BRP batches 4, 5 and 6.
Lackner F; Daas A; Terao E
Pharmeur Bio Sci Notes; 2015; 2015():1-10. PubMed ID: 26830155
[TBL] [Abstract][Full Text] [Related]
15. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
Dodt J; Costanzo A; Daas A; Hunfeld A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188
[TBL] [Abstract][Full Text] [Related]
16. A collaborative study to establish the 3rd International Standard for tissue plasminogen activator.
Sands D; Whitton CM; Merton RE; Longstaff C
Thromb Haemost; 2002 Aug; 88(2):294-7. PubMed ID: 12195703
[TBL] [Abstract][Full Text] [Related]
17. Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.
Fuchs F; Minor P; Daas A; Milne C
Pharmeuropa Bio; 2003 Jul; 2003(1):23-50. PubMed ID: 14563307
[TBL] [Abstract][Full Text] [Related]
18. An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays.
Baylis SA; Heath AB; Chudy M; Pisani G; Klotz A; Kerby S; Gerlich W
Vox Sang; 2008 May; 94(4):358-62. PubMed ID: 18266781
[TBL] [Abstract][Full Text] [Related]
19. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
[TBL] [Abstract][Full Text] [Related]
20. Collaborative study for the establishment of replacement batches of heparin low- molecular-mass for assay biological reference preparations.
Terao E; Daas A; Rautmann G; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):30-6. PubMed ID: 21144487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
